Results 21 to 30 of about 8,076,451 (351)
Chronic Disease and Injury Indicator Framework - Quick Stats, 2016 Edition
Health Promotion and Chronic Disease Prevention in Canada, 2016 null
Centre for Chronic Disease Prevention
doaj +1 more source
Promotion de la santé et prévention des maladies chroniques au Canada, 2017 null
Centre de prévention des maladies chroniques
doaj +1 more source
Cadre d'indicateurs des maladies chroniques et des blessures - Statistiques rapides, édition 2016
Promotion de la santé et prévention des maladies chroniques au Canada, 2016 null
Centre de prévention des maladies chroniques
doaj +1 more source
Promotion de la santé et prévention des maladies chroniques au Canada, 2016 null
Centre de prévention des maladies chroniques
doaj +1 more source
Hepatology, 2018 This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016 Practice Guidelines for Treatment of Chronic Hepatitis B and update the previous hepatitis B virus (HBV) guidelines from 2009. The 2018 updated guidance on chronic hepatitis B (
NA Terrault +8 more
semanticscholar +1 more source
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Nature reviews: Gastroenterology & hepatology, 2019 Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death worldwide. Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol addiction, metabolic liver disease (particularly nonalcoholic fatty liver disease)
J. D. Yang +5 more
semanticscholar +1 more source
Journal of Clinical Endocrinology and Metabolism, 2011 OBJECTIVE The objective was to provide guidelines to clinicians for the evaluation, treatment, and prevention of vitamin D deficiency with an emphasis on the care of patients who are at risk for deficiency. PARTICIPANTS The Task Force was composed of a
M. F. Holick +7 more
semanticscholar +1 more source
HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making.
PLoS Medicine, 2012 Antiretroviral therapy (ART) for those infected with HIV can prevent onward transmission of infection, but biological efficacy alone is not enough to guide policy decisions about the role of ART in reducing HIV incidence.
HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
doaj +1 more source
Chinese Diabetes Behavior and Lifestyle Intervention Guidelines (2024) [PDF]
Zhongguo quanke yixueBehavior and lifestyle interventions (BLIs) can reduce blood glucose and blood pressure, regulate blood lipids, control obesity, reduce cardiovas cular events and are a first-line treatment for chronic diseases such as diabetes mellitus.
Diabetes Prevention and Control Committee of Chinese Preventive Medicine Association
doaj +1 more source
Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality – results from two surveys (2016) [PDF]
Objectives: The World Health Organization (WHO) developed a European Regional Action Plan (EAP) to fast-track action towards the goal of eliminating viral hepatitis. Robust monitoring is essential to assess national programme performance.
De Brujin +11 more
core +1 more source